Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: The experience of a combined therapeutic protocol
International Orthopaedics, ISSN: 0341-2695, Vol: 30, Issue: 2, Page: 79-83
2006
- 63Citations
- 36Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations63
- Citation Indexes61
- 61
- CrossRef39
- Policy Citations2
- Policy Citation2
- Captures36
- Readers36
- 36
- Mentions1
- References1
- Wikipedia1
Article Description
The combination of radiotherapy and indomethacin for the prevention of heterotopic ossification (HO) in high-risk patients undergoing total hip arthroplasty (THA) has not been reported. The aim of this study was to present the experience of our department with this combined therapeutic protocol. Fifty-four patients who underwent THA received a single dose of 7 Gy of postoperative radiotherapy and 75 mg of indomethacin for 15 days. Patients were analysed for clinical and radiographical evidence of HO development at 1 year postoperatively. The overall radiographical incidence of HO was 20.4% (95% CI 10.6-33.5%), while only one patient with clinically significant HO was seen. Patients with secondary arthritis due to congenital hip disease had a statistically significant higher incidence of HO compared with those with osteoarthrosis. Clinical assessment using the Merle d'Aubigné score showed that patients with radiographic evidence of HO had a lower mean score compared with those with no evidence of HO. No treatment-related side effects were seen. Combined radiotherapy and indomethacin was effective in preventing heterotopic ossification after total hip arthroplasty. The evaluation of this efficacy compared with radiotherapy or NSAIDs alone should be the future target of larger randomised studies. © Springer-Verlag 2006.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33645291819&origin=inward; http://dx.doi.org/10.1007/s00264-005-0054-y; http://www.ncbi.nlm.nih.gov/pubmed/16482442; http://link.springer.com/10.1007/s00264-005-0054-y; https://dx.doi.org/10.1007/s00264-005-0054-y; https://link.springer.com/article/10.1007/s00264-005-0054-y; http://www.springerlink.com/index/10.1007/s00264-005-0054-y; http://www.springerlink.com/index/pdf/10.1007/s00264-005-0054-y
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know